CIK: 0001595855
Total reported value
$759.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CMRXEUR | Chimerix INC | Stock-Other | 16.38% | — | +6.62% | |
| 2 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 6.43% | — | — | |
| 3 | ✓ | Cempra INC | Stock-Other | 6.00% | — | — | |
| 4 | RTRXEUR | Retrophin INC | Stock-Other | 5.69% | — | -8.00% | |
| 5 | ✓ | Ariad Pharmaceuticals INC | Stock-Other | 5.29% | — | +1.67% | |
| 6 | ✓ | Pharmacyclics INC | Stock-Other | 5.25% | — | — | |
| 7 | CLVSEUR | Clovis Oncology INC | Stock-Other | 3.96% | — | — | |
| 8 | TTPHEUR | Tetraphase Pharmaceuticals I | Stock-Other | 3.81% | — | +11.79% | |
| 9 | GERN | Geron CORP | Stock-Other | 3.00% | — | +122.56% | |
| 10 | ✓ | Versartis INC | Stock-Other | 2.67% | — | — | |
| 11 | FGENEUR | Fibrogen INC | Stock-Other | 2.64% | — | — | |
| 12 | INSYEUR | Insys Therapeutics INC | Stock-Other | 2.61% | — | — | |
| 13 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 2.35% | — | +24.94% | |
| 14 | GNMK | Genmark Diagnostics INC | Stock-Other | 2.30% | — | -39.09% | |
| 15 | ✓ | Ophthotech Corporation | Stock-Other | 2.27% | — | +185.71% | |
| 16 | KRG | Kite Realty Group Trust | Stock-Real Estate | 2.21% | — | — | |
| 17 | CDXS | Codexis INC | Stock-Other | 2.20% | — | +2.01% | |
| 18 | ✓ | Medgenics Inc New | Stock-Other | 2.17% | — | — | |
| 19 | ✓ | Imprimis Pharma Immy | Stock-Other | 2.12% | — | +11.44% | |
| 20 | ✓ | Oncothyreon INC | Stock-Other | 1.92% | — | — | |
| 21 | CSIIEUR | Cardiovascular Systems INC | Stock-Other | 1.90% | — | — | |
| 22 | ✓ | Flamel Technologies-sp Adr | Stock-Other | 1.77% | — | — | |
| 23 | LAB | Standard Biotools INC | Stock-Other | 1.62% | — | +41.79% | |
| 24 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 1.56% | — | — | |
| 25 | TREUR | Trillium Therapeutics INC | Stock-Other | 1.52% | — | — | |
| 26 | SUPN | Supernus Pharmaceuticals INC | Stock-Healthcare | 1.47% | — | — | |
| 27 | CPRX | Catalyst Pharmaceuticals INC | Stock-Healthcare | 1.46% | — | — | |
| 28 | ✓ | Horizon Pharma PLC | Stock-Other | 1.43% | — | — | |
| 29 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.43% | — | — | |
| 30 | ✓ | Accelerate Diagnostics Inc | Stock-Other | 0.97% | — | +12.11% | |
| 31 | ✓ | Celgene CORP | Stock-Other | 0.92% | — | -12.88% | |
| 32 | ✓ | Tenax Therapeutics INC | Stock-Other | 0.85% | — | — | |
| 33 | ✓ | Evoke Pharma INC | Stock-Other | 0.72% | — | -10.11% | |
| 34 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 0.51% | — | — | |
| 35 | CARAEUR | Cara Therapeutics INC | Stock-Other | 0.40% | — | — | |
| 36 | ✓ | Biolinerx Ltd-spons Adr | Stock-Other | 0.20% | — | -48.98% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GERN | Geron CORP | +1.7% | +122.56% | Add |
| 2 | ✓ | Cempra INC | +1.7% | — | Unchanged |
| 3 | ✓ | Ophthotech Corporation | +1.2% | +185.71% | Add |
| 4 | TTPHEUR | Tetraphase Pharmaceuticals I | +1.2% | +11.79% | Add |
| 5 | AGIO | Agios Pharmaceuticals INC | +1% | — | Unchanged |
| 6 | LAB | Standard Biotools INC | +0.3% | +41.79% | Add |
| 7 | CMRXEUR | Chimerix INC | +0.1% | +6.62% | Add |
| 8 | ALNY | Alnylam Pharmaceuticals INC | -0.3% | — | Unchanged |
| 9 | ✓ | Biolinerx Ltd-spons Adr | -0.4% | -48.98% | Trim |
| 10 | CSIIEUR | Cardiovascular Systems INC | -0.4% | — | Unchanged |
| 11 | ✓ | Evoke Pharma INC | -0.4% | -10.11% | Trim |
| 12 | ✓ | Accelerate Diagnostics Inc | -0.5% | +12.11% | Add |
| 13 | ✓ | Imprimis Pharma Immy | -0.8% | +11.44% | Add |
| 14 | ✓ | Celgene CORP | -0.8% | -12.88% | Trim |
| 15 | CDXS | Codexis INC | -0.9% | +2.01% | Add |
| 16 | CLVSEUR | Clovis Oncology INC | -0.9% | — | Unchanged |
| 17 | ✓ | Ariad Pharmaceuticals INC | -1% | +1.67% | Add |
| 18 | CPRX | Catalyst Pharmaceuticals INC | -1.1% | — | Unchanged |
| 19 | INSYEUR | Insys Therapeutics INC | -1.1% | — | Unchanged |
| 20 | RTRXEUR | Retrophin INC | -1.3% | -8.00% | Trim |
| 21 | RARE | Ultragenyx Pharmaceutical In | -1.4% | +24.94% | Add |
| 22 | GNMK | Genmark Diagnostics INC | -1.6% | -39.09% | Trim |
| 23 | ✓ | Pharmacyclics INC | -2.5% | — | Unchanged |
| 24 | ✓ | Versartis INC | — | NEW | New buy |
| 25 | FGENEUR | Fibrogen INC | — | NEW | New buy |
| 26 | ✓ | Inspiremd INC | — | EXIT | Sold out |
| 27 | KRG | Kite Realty Group Trust | — | NEW | New buy |
| 28 | ✓ | Medgenics Inc New | — | NEW | New buy |
| 29 | ✓ | Bind Therapeutics INC | — | EXIT | Sold out |
| 30 | ✓ | Oncothyreon INC | — | NEW | New buy |
| 31 | ✓ | Flamel Technologies-sp Adr | — | NEW | New buy |
| 32 | PRTA | Prothena Corporation plc | — | EXIT | Sold out |
| 33 | PRTKEUR | Paratek Pharmaceuticals INC | — | NEW | New buy |
| 34 | TREUR | Trillium Therapeutics INC | — | NEW | New buy |
| 35 | SUPN | Supernus Pharmaceuticals INC | — | NEW | New buy |
| 36 | ✓ | Horizon Pharma PLC | — | NEW | New buy |
| 37 | ✓ | Aegerion Pharmaceuticals INC | — | EXIT | Sold out |
| 38 | DRNAUSD | Dicerna Pharmaceuticals INC | — | EXIT | Sold out |
| 39 | ✓ | Tenax Therapeutics INC | — | NEW | New buy |
| 40 | ✓ | Celator Pharmaceuticals INC | — | EXIT | Sold out |
| 41 | NBIX | Neurocrine Biosciences INC | — | NEW | New buy |
| 42 | CARAEUR | Cara Therapeutics INC | — | NEW | New buy |
| 43 | ✓ | Kips Bay Medical INC | — | EXIT | Sold out |